LeBlanc, R., Thiant, S., Terra, R., Ahmad, I., Claveau, J., Bambace, N., . . . Roy, J. A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant. MDPI AG.
Chicago Style (17th ed.) CitationLeBlanc, Richard, et al. A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant. MDPI AG.
MLA (9th ed.) CitationLeBlanc, Richard, et al. A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant. MDPI AG.
Warning: These citations may not always be 100% accurate.